RRR-α-tocopheryl succinate enhances TGF-β1, -β2, and -β3 and TGF- βR-II expression by human MDA-MB-435 breast cancer cells

Nutrition and Cancer

Volumn 26, Issue 2, 1996, Pages 237-250

  Charpentier, April ^a   Simmons Menchaca, Marla ^a   Yu, Weiping ^a   Zhao, Bihong ^a   Qian, Ming ^a   Heim, Karen ^a   Sanders, Bob G ^a   Kline, Kimberly ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; DNA; MESSENGER RNA; RECEPTOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL;

EID: 0029758859     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589609514480     Document Type: Article

References (61)

1. Charpentier, A, Groves, S, Simmons-Menchaca, M, Turley, J, Zhao, B, et al.: "RRR-α-Tocopheryl Succinate Inhibits Proliferation and Enhances Secretion of Transforming Growth Factor-β (TGF-β) by Human Breast Cancer Cells." Nutr Cancer 19, 225-239, 1993.
2. One, K, Yu, W, Zhao, B, Israel, K, Charpentier, A, et al.: "Vitamin E Succinate: Mechanisms of Action as Tumor Cell Growth Inhibitor." In Nutrients in Cancer Prevention and Treatment. KN Prasad, L Santamaria, and RM Williams (eds). Totowa, NJ: Humana, 1995, pp 189-205.
3. Schwartz, J, and Shklar, G: "The Selective Cytotoxic Effect of Carotenoids and α-Tocopherol on Human Cancer Cell Lines In Vitro." J Oral Maxillofac Surg 50, 367-373, 1992.
4. Prasad, KN, and Edwards-Prasad, J: "Vitamin E and Cancer Prevention: Recent Advances and Future Potentials." J Am Coll Nutr 11, 487-500, 1992.
5. Schwartz, J: "The Clinical Control of Tumor Cell Growth Through the Action of Carotenoids, Retinoids and Tocopherols." In Adjuvant Nutrition in Cancer Treatment, P Quillin and RM Williams (eds). Arlington Heights, IL: Cancer Treat Found, 1993, pp 173-233.
6. Kline, K, Cochran, GS, and Sanders, BG: "Growth-Inhibitory Effects of Vitamin E Succinate on Retrovirus-Transformed Tumor Cells In Vitro." Nutr Cancer 14, 27-41, 1990.
7. Turley, JM, Sanders, BG, and Kline, K: "RRR-α-Tocopheryl Succinate Modulation of Human Promyelocytic Leukemia (HL-60) Cell Proliferation and Differentiation." Nutr Cancer 18, 201-213, 1992.
8. Simmons-Menchaca, M, Qian, M, Yu, W, Sanders, BG, and Kline, K: "RRR-α-Tocopheryl Succinate Inhibits DNA Synthesis and Enhances the Production and Secretion of Biologically Active Transforming Growth Factor-Beta (TGF-β) by Avian Retrovirus-Transformed Lymphoid Cells." Nutr Cancer 24, 171-185, 1995.
9. Prasad, KN, Cohrs, RJ, and Sharma, OK: "Decreased Expressions of c-myc and H-ras Oncogenes in Vitamin E Succinate Induced Morphologically Differentiated Murine B-16 Melanoma Cells in Culture." Cell Biol 68, 1250-1255, 1990.
10. Cohrs, RJ, Torelli, S, Prasad, KN, Edwards-Prasad, J, and Sharma, OK: "Effect of Vitamin E Succinate and a cAMP-Stimulating Agent on the Expression of c-myc, N-myc, and H-ras in Murine Neuroblastoma Cells." Int J Dev Neurosci 9, 187-194, 1991.
11. Turley, JM, Funakoshi, S, Ruscetti, FW, Kasper, J, Murphy, WJ, et al.: "Growth Inhibition and Apoptosis of RL Human B Lymphoma Cells by Vitamin E Succinate and Retinoic Acid: Role for Transforming Growth Factor β." Cell Growth Differ 6, 655-663, 1995.
12. Qian, M, Sanders, BG, and Kline K: "RRR-α-Tocopheryl Succinate Induces Apoptosis in Avian Retrovirus-Transformed Lymphoid Cells." Nutr Cancer 25, 9-26, 1996.
13. Israel, K, Sanders, BG, and Kline, K: "RRR-α-Tocopheryl Succinate Inhibits the Proliferation of Human Prostatic Tumor Cells With Defective Cell Cycle/Differentiation Pathways." Nutr Cancer 24, 161-169, 1995.
14. Wakefield, LM, Collette, AA, McCune, BK, and Sporn, MB: "Roles for Transforming Growth Factors-β in the Genesis, Prevention, and Treatment of Breast Cancer." In Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, RB Dickson and ME Lippman (eds). Boston, MA: Kluwer Academic, 1991, pp 79-136.
15. Colletta, AA, Wakefield, LM, Howell, FV, Danielpour, D, Baum, M, et al.: "The Growth Inhibition of Human Breast Cancer Cells by a Novel Synthetic Progestin Involves the Induction of Transforming Growth Factor Beta." J Clin Invest 87, 277-283, 1991.
16. 1 and Its Latent Form Binding Protein in Cultured Breast Carcinoma Cells." Cancer Res 55, 1540-1546, 1995.
17. Roberts, AB, and Sporn, MB: "The Transforming Growth Factor-βs." In Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology, MB Sporn and AB Roberts (eds). New York: Springer-Verlag, 1990, pp 419-472.
18. Massague, J: "The Transforming Growth Factor-β Family." Annu Rev Cell Biol 6, 597-641, 1990.
19. Lyons, RM, and Moses, HL: "Transforming Growth Factors and the Regulation of Cell Proliferation." Eur J Biochem 187, 467-473, 1990.
20. Sporn, MB, and Roberts, AB: "TGF-β Problems and Prospects." Cell Regul 1, 875-882, 1990.
21. Burt, DW, and Law, AS: "Evolution of the Transforming Growth Factor-Beta Superfamily." Prog Growth Factor Res 5, 99-118, 1994.
22. Price, JE, Polyzos, A, Zhang, RD, and Daniels, LM: "Tumorigenicity and Metastasis of Human Breast Cancer Carcinoma Cell Lines in Nude Mice." Cancer Res 50, 717-721, 1990.
23. Abe, M, Harpel, JG, Metz, CN, Nunes, I, Loskutoff, DJ, et al.: "An Assay for Transforming Growth Factor-β Using Cells Transfected With a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct." Anal Biochem 216, 267-284, 1994.
24. Massague, J: "Identification of Receptors for Type-β Transforming Growth Factor." Methods Enzymol 146, 174-195, 1987.
25. Laemmli, UK: "Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4." Nature 227, 680-685, 1970.
26. Maniatis, T, Fritsch, EF, and Sambrook, J: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
27. Okayama, H, and Berg, P: "A cDNA Cloning Vector That Permits Expression of cDNA Inserts in Mammalian Cells." Mol Cell Biol 3, 280-289, 1983.
28. 1 mRNAs." J Biol Chem 263, 18313-18317, 1988.
29. 1 Genes." Cell Growth Differ 2, 77-83, 1991.
30. Franzen, P, ten Dijke, P, Ichijo, H, Yamashita, H, Schulz, P, et al.: "Cloning of a TGFβ Type I Receptor That Forms a Heteromeric Complex With the TGFβ Type II Receptor." Cell 75, 681-692, 1993.
31. Lin, HY, Wang, X-F, Ng-Eaton, E, Weinberg, RA, and Lodish, F: "Expression of the TGF-β Type II Receptor, a Functional Transmembrane Serine/Threonine Kinase." Cell 68, 775-785, 1992.
32. Wang, X-F, Lin, HY, Ng-Eaton, E, Downward, J, Lodish, HF, et al.: "Expression Cloning and Characterization of the TGF-β Type II Receptor." Cell 67, 797-805, 1991.
33. Sporn, MB, and Roberts, AB: "Interactions of Retinoids and Transforming Growth Factor-Beta in Regulation of Cell Differentiation and Proliferation." Mol Endocrinol 5, 3-7, 1991.
34. Roberts, AB, Thompson, NL, Heine, U, Flanders, C, and Sporn, MB: "Transforming Growth Factor-β: Possible Roles in Carcinogenesis." Br J Cancer 57, 594-600, 1988.
35. Wakefield, LM, and Sporn, MB: "Suppression of Carcinogenesis: a Role for TGF-Beta and Related Molecules in Prevention of Cancer." In Tumor Suppressor Genes, G Klein (ed). New York: Dekker, 1990, pp 217-243.
36. Keski-Oja, J, Leof, EB, Lyons, RM, Coffey, RJ, and Moses, HL: "Transforming Growth Factors and Control of Neoplastic Cell Growth." J Cell Biochem 33, 95-107, 1987.
37. Markowitz, S, Wang, J, Myeroff, L, Parsons, R, Sun L, et al.: "Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells With Microsatellite Instability. Science 268, 1336-1338, 1995.
38. Massague, J, Andres, J, Attisano, L, Cheifetz, S, Lopez-Casillas, F, et al.: "TGF-β Receptors." Mol Reprod Dev 32, 99-104, 1992.
39. Wrana, JL, Attisano, L, Wieser, R, Ventura, F, and Massague, J: "Mechanism of Activation of the TGF-β Receptor." Nature 370, 341-347, 1994.
40. Massague, J, Attisano, L, and Wrana, JL: "The TGF-β Family and Its Composite Receptors." Trends Cell Biol 4, 172-178, 1994.
41. Zhou, G-HK, Sechrist, GL, Periyasamy, S, Brattain, MG, and Mulder, KM: "Transforming Growth Factor β Isoform-Specific Differences in Interactions With Type I and II Transforming Growth Factor β Receptors." Cancer Res 5, 2056-2062, 1995.
42. 2 in Cultured Keratinocytes and Mouse Epidermis." Cell Regul 1, 87-97, 1989.
43. Glick, AB, Danielpour, D, Morgan, D, Sporn, MB, and Yuspa, SH: "Induction and Autocrine Receptor Binding of Transforming Growth Factor-Beta 2 During Terminal Differentiation of Primary Mouse Keratinocytes." Mol Endocrinol 4, 46-52, 1990.
44. 1-Mediated Autocrine Inhibition." Blood 77, 1248-1255, 1991.
45. 1 and Its Receptors During All-Trans-Retinoic Acid (RA) Treatment of RA-Responsive Human Neuroblastoma Cell Lines." Cancer Res 55, 2380-2386, 1995.
46. Letterio, JJ, Anzano, MA, Roberts, AB, and Sporn, MB: "Novel Vitamin D Analog Enhances Differentiating Effects of Transforming Growth Factor Beta-1 (TGF-β) in Myeloid Leukemia Cell Lines" (abstr). Proc Am Assoc Cancer Res 34, 46, 1993.
47. 3 in MG-63 Osteoblastic Cells." Biochem Biophys Res Commun 204, 918-923, 1994.
48. 1 in Human Breast Cancer In Vivo Following Tamoxifen Treatment." Cancer Res 52, 4261-4264, 1992.
49. Colletta, AA, Wakefield, LM, Howell, FV, van Roozendaal, KEP, Danielpour, D, et al.: "Anti-Ooestrogens Induce the Secretion of Active Transforming Growth Factor Beta From Human Fetal Fibroblasts." Br J Cancer 62, 405-409, 1990.
50. Wakefield, L, Kim, S-J, Glick, A, Winokur, T, Colletta, A, et al.: "Regulation of Transforming Growth Factor-β Subtypes by Members of the Steroid Hormone Superfamily. J Cell Sci Suppl 13, 139-148, 1990.
51. Mills, JJ, Chari, RS, Boyer, IJ, Gould, MN, and Jirtle, RL: "Induction of Apoptosis in Liver Tumors by the Monoterpene Perillyl Alcohol." Cancer Res 55, 979-983, 1995.
52. Moore, DD: "Diversity and Unity in the Nuclear Hormone Receptors: a Terpenoid Receptor Superfamily." New Biologist 2, 100-105, 1990.
53. Haag, JD, Lindstrom, MJ, and Gould, MN: "Limonene-Induced Regression of Mammary Carcinomas." Cancer Res 52, 4021-4026, 1992.
54. Haag, JD, and Gould, MN: "Mammary Carcinoma Regression Induced by Perillyl Alcohol, a Hydroxylated Analog of Limonene." Cancer Chemother Pharmacol 34, 477-483, 1994.
55. Rama, B, and Prasad, KN: "Effects of dl-Alpha-Tocopheryl Succinate in Combination With Sodium Butyrate and cAMP Stimulating Agent on Neuroblastoma Cells in Culture." Int J Cancer 34, 863-867, 1984.
56. Prasad, KN, Kentroti, S, Edwards-Prasad, J, Vernadakis, A, Mohammed I, et al.: "Modification of the Expression of Adenosine 3′,5′-Cyclic Monophosphate-Induced Differentiated Functions in Neuroblastoma Cells by Beta-Carotene and d-Alpha-Tocopheryl Succinate." J Am Coll Nutr 13, 298-303, 1994.
57. Sahu, SN, Edwards-Prasad, J, and Prasad, KN: "Effect of Alpha Tocopheryl Succinate on Adenylate Cyclase Activity in Murine Neuroblastoma Cells in Culture." J Am Coll Nutr 7, 285-293, 1988.
58. Prasad, KC: "Induction of Differentiated Phenotypes in Melanoma Cells by a Combination of an Adenosine 3′,5′-Cyclic Monophosphate Stimulating Agent and d-alpha Tocopheryl Succinate." Cancer Lett 44, 17-22, 1989.
59. 3 mRNA in Human Breast Cancer Cells." Mol Cell Biol 14, 619-628, 1994.
60. Fuqua, SAW, Chamness, GC, and McGuire, WL: "Estrogen Receptor Mutations in Breast Cancer." J Cell Biochem 51, 135-139, 1993.
61. Turley, JM, Sanders, BG, and Kline, K: "Vitamin E Succinate Induction of HL-60 Cell Adhesion: a Role for Fibronectin and a 72-kDa Fibronectin-Binding Molecule." Nutr Cancer 23, 43-54, 1995.